Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sunitinib in Recurrent Malignant Gliomas
NCT00499473Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Jun 2007
- Primary completion
- Jun 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sunitinib in malignant glioma, sponsored by National Cancer Institute. Started Jun 2007; status: completed.
02
Drugs
sunitinib
03
Conditions
malignant glioma
Beyond the preview
Go deeper on NCT00499473.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00499473.